Correction to: Ganglioglioma with adverse clinical outcome and atypical histopathological features were defined by alterations in PTPN11/KRAS/NF1 and other RAS-/MAP-Kinase pathway genes
Lucas Hoffmann(Universitätsklinikum Erlangen), Samir Jabari(Universitätsklinikum Erlangen), Patrick N. Harter(Ludwig-Maximilians-Universität München), Ingmar Blümcke(Friedrich-Alexander-Universität Erlangen-Nürnberg), Hajo M. Hamer(Universitätsklinikum Erlangen), Roland Coras(Bethel University), Javier A. López-Rivera(Children's Health Council), Imad Najm(Cleveland Clinic), Tom Pieper(Schön Klinik Vogtareuth), Costin Leu(Broad Institute), Thilo Kalbhenn(Bielefeld University), Jochen Herms(German Center for Neurodegenerative Diseases), Christian G. Bien(Bielefeld University), Peter Nürnberg(University of Cologne), Till Hartlieb(Schön Klinik Vogtareuth), Manfred Kudernatsch(Schön Klinik Vogtareuth), Katja Kobow(Universitätsklinikum Erlangen), Markus Müller(SIB Swiss Institute of Bioinformatics), Sebastian Brandner(Universitätsklinikum Erlangen), Karl Rössler(Bethel University), Dennis Lal(Broad Institute)
Cited by 3
Related Papers
A clinical approach to diagnosis of autoimmune encephalitis
|The Lancet Neurology|2016|4.4k
The clinicopathologic spectrum of focal cortical dysplasias: A consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission1
|Epilepsia|2010|1.7k
Histopathological Findings in Brain Tissue Obtained during Epilepsy Surgery
|New England Journal of Medicine|2017|916
The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI–neuropathology diagnostic accuracy study
|The Lancet Neurology|2022|651
Classification of patients with sepsis according to blood genomic endotype: a prospective cohort study
|The Lancet Respiratory Medicine|2017|645